Screening asymptomatic low-risk individuals for coronary heart disease: Issues and controversies

Journal of Nuclear Cardiology

Volumn 11, Issue 4, 2004, Pages 382-387

  Shaw, Leslee J ^a   Blumenthal, Roger S ^b   Raggi, Paolo ^c  

^a Atlanta Cardiovasc Res Institute   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAYES THEOREM; CARDIOVASCULAR RISK; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; EDITORIAL; ELECTRON BEAM TOMOGRAPHY; EPIDEMIOLOGICAL DATA; EXERCISE ELECTROCARDIOGRAPHY; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEART INFARCTION; HEART MUSCLE PERFUSION; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; PATIENT CARE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VALIDATION PROCESS;

CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; COST-BENEFIT ANALYSIS; EPIDEMIOLOGIC METHODS; EVIDENCE-BASED MEDICINE; HUMANS; MASS SCREENING; MODELS, ECONOMETRIC; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 4344659194     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2004.04.007     Document Type: Editorial

References (33)

1. Mark DB, Shaw LJ, Lauer MS, O'Malley PO, Heidenreich P. Is atherosclerotic imaging cost effective? J Am Coll Cardiol 2003;41:1906-1917
2. Goldman L. Garber A.M. Grover S.A. Hlatky M.A. 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard for CAD events. Task Force 6. Cost effectiveness of assessment and management of risk factors J Am Coll Cardiol 27 1996 1020-1030
3. Russell L.B. Gold M.R. Siegel J.E. Daniels N. Weinstein M.C. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine JAMA 276 1996 1172-1177
4. Weinstein M.C. Stason W.B. Cost-effectiveness of interventions to prevent or treat coronary heart disease Annu Rev Public Health 6 1985 41-63
5. Mora S. Redberg R.F. Cui Y. et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: A 20-year follow-up of the lipid research clinics prevalence study JAMA 290 2003 1600-1607
6. Gulati M. Pandey D.K. Arnsdorf M.F. et al. Exercise capacity and the risk of death in women: The St James Women Take Heart Project Circulation 108 2003 1554-1559
7. Shaw L.J. Redberg R.F. From clinical trials to public health policy: The path from imaging to screening Am J Cardiol 88 2001 62E-65E
8. Greenland P. Smith S.C. Jr. Grundy S.M. Improving coronary heart disease risk assessment in asymptomatic people: Role of traditional risk factors and noninvasive cardiovascular tests Circulation 104 2001 1863-1867
9. Grundy S.M. Pasternak R. Greenland P. Smith S. Jr. Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology Circulation 100 1999 1481-1492
10. Wilson P.W. D'Agostino R.B. Levy D. et al. Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837-1847
11. O'Rourke R.A. Brundage B.H. Froelicher V.F. et al. American College of Cardiology/American Heart Association Expert Consensus document on electron beam computed tomography for the diagnosis of coronary artery disease Circulation 102 2000 126-140
12. Redberg R.F. Vogel R.A. Criqui M.H. et al. 34th Bethesda Conference: Task force #3-what is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? J Am Coll Cardiol 41 2003 1886-1898
13. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
14. Nasir K, Redberg RF, Budoff MJ, et al. Utility of stress testing and coronary calcification measurement for detection of coronary artery disease in women. Arch Int Med. In press 2004
15. Pasternak R.C. Abrams J. Greenland P. et al. 34th Bethesda Conference: Task force #1-identification of coronary heart disease risk: Is there a detection gap? J Am Coll Cardiol 41 2003 1863-1874
16. Blumenthal R.S. Becker D.M. Yanek L.R. et al. Detecting occult coronary disease in a high-risk asymptomatic population Circulation 107 2003 702-707
17. Smith S.C. Jr. Blair S.N. Bonow R.O. et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology J Am Coll Cardiol 38 2001 1581-1583
18. Budoff MJ, Blumenthal RS, Carr JJ, et al. Assessment of coronary artery calcification by electron beam and multidetector computed tomography: A statement for health professionals from the American Heart Association. Circulation. In press 2004
19. Shaw L.J. Raggi P. Schisterman E. Berman D.S. Callister T.Q. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality Radiology 28 2003 826-833
20. Greenland P. LaBree L. Azen S.P. Doherty T.M. Detrano R.C. Coronary artery calcium combined with Framingham score for risk prediction in asymptomatic individuals JAMA 291 2004 210-215
21. Shaw L.J. Raggi P. Schisterman E. Berman D.S. Callister T.Q. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality Radiology 28 2003 826-833
22. Available from: URL: http://www.ahrq.gov/clinic/uspstf/uspsacad.htm. Accessed March 2, 2004
23. Belch J.J.F. Topol E.J. Agnelli G. et al. Critical issues in peripheral arterial disease detection and management Arch Int Med 163 2003 884-892
24. Kennedy J. Shavelle R. Wang S. Budoff M. Detrano R.C. Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography Am Heart J 135 1998 696-702
25. Available from: URL: http://www.americanheart.org/downloadable/ heart/1079736729696HDSStats2004UpdateREV3-19-04.pdf. Accessed April 20, 2004
26. Shaw L.J. Raggi P. Berman D.S. Callister T.Q. Cost effectiveness of screening for cardiovascular disease with measures of coronary calcium Prog Cardiov Dis 46 2003 171-184
27. Available from: URL: www.cms.gov, Office of the Actuary, National Health Statistics Group. Accessed March 2, 2004
28. Available from: URL: www.nhlbi.nih.giv/guidelines/cholesterol/index.htm. Accessed March 1, 2004
29. Conroy R.M. Pyorala K. Fitzgerald A.P. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project Eur Heart J 24 2003 987-1003
30. Raggi P. Shaw L.J. Berman D.S. Callister T.Q. Prognostic value of coronary artery calcium screening in subjects with and without diabetes J Am Coll Cardiol 43 2004 1663-1669
31. Gibbons RJ, Abrams J, Chatterjee K, et al, American College of Cardiology, American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003 1;41:159-168
32. Califf R.M. Armstrong P.W. Carver J.R. D'Agostino R.B. Strauss W.E. Stratification of patients into high, medium, and low risk subgroups for purposes of risk factor management J Am Coll Cardiol 27 1996 964-1047
33. Blumenthal R.S. Becker D.M. Moy T.F. et al. Exercise thallium scintigraphy predicts future clinically manifest coronary heart disease in a high risk asymptomatic population Circulation 93 1996 915-923